TET3 and neurodevelopmental disorder: In this work, we have identified a robust genome-wide DNA methylation signature in whole blood, which differentiates pathogenic from non-pathogenic variants in TET3, has greatly aided in the rapid characterization of this newly-described neurodevelopmental disorder, and will be of critical value to facilitate ongoing diagnosis of BEFAHRS with its non-specific phenotypic features.